title: A pilot study of idiotypic vaccination for follicular B-cell lymphoma using a genetic approach. CRC NO: 92/33. Protocol NO: PH1/027.
authors.forename: R E
authors.initials: RE
authors.lastname: Hawkins
authors.forename: S J
authors.initials: SJ
authors.lastname: Russell
authors.forename: R
authors.initials: R
authors.lastname: Marcus
authors.forename: L J
authors.initials: LJ
authors.lastname: Ashworth
authors.forename: J
authors.initials: J
authors.lastname: Brissnik
authors.forename: J
authors.initials: J
authors.lastname: Zhang
authors.forename: G
authors.initials: G
authors.lastname: Winter
authors.forename: N M
authors.initials: NM
authors.lastname: Bleehen
authors.forename: M M
authors.initials: MM
authors.lastname: Shaw
authors.forename: L
authors.initials: L
authors.lastname: Williamson
authors.forename: W
authors.initials: W
authors.lastname: Ouwehand
authors.forename: F
authors.initials: F
authors.lastname: Stevenson
authors.forename: T
authors.initials: T
authors.lastname: Hamblin
authors.forename: D
authors.initials: D
authors.lastname: Oscier
authors.forename: D
authors.initials: D
authors.lastname: Zhu
authors.forename: C
authors.initials: C
authors.lastname: King
authors.forename: S
authors.initials: S
authors.lastname: Kumar
authors.forename: A
authors.initials: A
authors.lastname: Thompsett
authors.forename: G T
authors.initials: GT
authors.lastname: Stevenson
mesh_terms: D000888:Antibodies, Anti-Idiotypic; D002985:Clinical Protocols; D017321:Clinical Trials, Phase I as Topic; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007135:Immunoglobulin Variable Region / Q000235:genetics* / Q000276:immunology; D007167:Immunotherapy / Q000009:adverse effects / Q000379:methods*; D007273:Injections, Intramuscular; D016393:Lymphoma, B-Cell / Q000276:immunology / Q000628:therapy; D008224:Lymphoma, Follicular / Q000276:immunology* / Q000628:therapy*; D008297:Male; D010865:Pilot Projects; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D014614:Vaccines, Synthetic / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*
chemical_list: D000888:Antibodies, Anti-Idiotypic; D007135:Immunoglobulin Variable Region; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic